HK Stock MarketDetailed Quotes
09939 KINTOR PHARMA-B
- 1.060
- -0.010-0.93%
Not Open Nov 25 16:08 CST
474.35MMarket Cap-470P/E (TTM)
1.070High1.040Low212.00KVolume1.070Open1.070Pre Close224.59KTurnover0.05%Turnover RatioLossP/E (Static)447.50MShares2.05052wk High1.11P/B474.35MFloat Cap0.79052wk Low--Dividend TTM447.50MShs Float89.000Historical High--Dividend LFY2.80%Amplitude0.790Historical Low1.059Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
KINTOR PHARMA-B Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ---- | ---- | ---- | ---- | ---- | --34.23M | ---- | ---- | ---- | ---- |
| Operating income | 34.23M | |||||||||
| Cost of sales | --1.13M | ---42.23M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating expenses | 1.13M | -42.23M | ||||||||
| Gross profit | 1.13M | -42.23M | 34.23M | |||||||
| Selling expenses | 79.58%-1.76M | 65.64%-6.98M | 18.80%-8.64M | -38.29%-20.33M | -72.88%-10.64M | -70.35%-14.7M | -71.21%-6.16M | -2,467.86%-8.63M | ---3.6M | ---336K |
| Administrative expenses | 33.78%-33.91M | 32.67%-89.05M | 21.80%-51.2M | -28.08%-132.25M | -32.04%-65.48M | -33.99%-103.26M | -10.15%-49.59M | -135.21%-77.06M | -271.63%-45.02M | -35.92%-32.76M |
| Research and development expenses | 76.11%-39.33M | -13.40%-938.91M | 64.30%-164.62M | -7.82%-827.97M | -63.40%-461.09M | -133.58%-767.94M | -90.18%-282.18M | -53.61%-328.76M | -65.92%-148.38M | -129.64%-214.02M |
| Special items of operating profit | -57.76%7.62M | -50.19%17.94M | -14.53%18.03M | 198.75%36.02M | 56.01%21.09M | 113.34%12.06M | 283.65%13.52M | -590.46%-90.4M | -15.71%3.52M | 43.81%18.43M |
| Operating profit | 67.90%-66.26M | -12.14%-1.06B | 60.00%-206.44M | -12.50%-944.53M | -59.10%-516.11M | -66.31%-839.6M | -67.68%-324.4M | -120.76%-504.85M | -98.71%-193.46M | -118.89%-228.69M |
| Financing cost | 13.80%-5.22M | -18.36%-9.69M | -162.59%-6.05M | -228.27%-8.19M | -62.25%-2.3M | 26.15%-2.49M | 28.46%-1.42M | 13.19%-3.38M | -73.21%-1.99M | 2.92%-3.89M |
| Share of profits of associates | ---- | 109.15%52K | ---131K | ---568K | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 66.38%-71.48M | -12.12%-1.07B | 58.99%-212.62M | -13.20%-953.28M | -59.11%-518.41M | -65.69%-842.1M | -66.71%-325.82M | -118.52%-508.23M | -98.41%-195.45M | -114.39%-232.58M |
| Tax | -103.55%-18K | 841.11%8.04M | 5,733.33%507K | ---1.09M | ---9K | ---- | ---- | ---73K | ---- | ---- |
| After-tax profit from continuing operations | 66.29%-71.49M | -11.15%-1.06B | 59.09%-212.11M | -13.33%-954.37M | -59.11%-518.42M | -65.67%-842.1M | -66.71%-325.82M | -118.55%-508.3M | -98.41%-195.45M | -114.39%-232.58M |
| Earning after tax | 66.29%-71.49M | -11.15%-1.06B | 59.09%-212.11M | -13.33%-954.37M | -59.11%-518.42M | -65.67%-842.1M | -66.71%-325.82M | -118.55%-508.3M | -98.41%-195.45M | -114.39%-232.58M |
| Profit attributable to shareholders | 66.29%-71.49M | -11.15%-1.06B | 59.09%-212.11M | -13.33%-954.37M | -59.11%-518.42M | -65.67%-842.1M | -66.71%-325.82M | -118.55%-508.3M | -98.41%-195.45M | -114.39%-232.58M |
| Basic earnings per share | 66.00%-0.17 | 2.37%-2.47 | 64.79%-0.5 | -7.20%-2.53 | -52.69%-1.42 | -43.90%-2.36 | -29.17%-0.93 | -69.07%-1.64 | -67.44%-0.72 | 80.48%-0.97 |
| Diluted earnings per share | 66.00%-0.17 | 2.37%-2.47 | 64.79%-0.5 | -7.20%-2.53 | -52.69%-1.42 | -43.90%-2.36 | -29.17%-0.93 | -69.07%-1.64 | -67.44%-0.72 | 80.48%-0.97 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data